Advances in the diagnosis, pathogenesis and treatment of CIDP

@article{Dalakas2011AdvancesIT,
  title={Advances in the diagnosis, pathogenesis and treatment of CIDP},
  author={MarinosC. Dalakas},
  journal={Nature Reviews Neurology},
  year={2011},
  volume={7},
  pages={507-517}
}
Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic autoimmune neuropathy. Despite clinical challenges in diagnosis—owing in part to the existence of disease variants, and different views on how many electrophysiological abnormalities are needed to document demyelination—consensus criteria seem to have been reached for research or clinical practice. Current standard of care involves corticosteroids, intravenous immunoglobulin (IVIg) and/or plasmapheresis, which… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 84 CITATIONS, ESTIMATED 48% COVERAGE

Fulminant Central Plus Peripheral Nervous System Demyelination without Antibodies to Neurofascin.

  • The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  • 2016
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.

  • The Journal of clinical investigation
  • 2015
VIEW 16 EXCERPTS
CITES BACKGROUND

Pathophysiology of autoimmune polyneuropathies.

  • Presse medicale
  • 2013
VIEW 10 EXCERPTS
CITES BACKGROUND

Chronisch immunvermittelte Neuropathien – Diagnostik und Therapie

  • Fortschritte der Neurologie-Psychiatrie
  • 2018
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Terminal complement activation is increased and associated with disease severity in CIDP

  • Annals of clinical and translational neurology
  • 2016
VIEW 4 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

April 2015 pulmonary case of the month: get down

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2012
2019

CITATION STATISTICS

  • 11 Highly Influenced Citations

  • Averaged 8 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 160 REFERENCES

An open label clinical trial of complement inhibition in multifocal motor neuropathy

Fitzpatrick, M A.
  • J. Peripher. Nerv. Syst. 16,
  • 2011

Current diagnosis of CIDP: the need for biomarkers.

  • Journal of the peripheral nervous system : JPNS
  • 2011

MRI assessment including apparent diffusion coefficient

Adachi, Y. et al. Brachial, lumbar plexuses in chronic inflammatory demyelinating polyradiculoneuropathy
  • Neuroradiology 53, 3–11
  • 2011

Potential biomarkers for monitoring therapeutic responses to IVIg and other therapies in CIDP

M. C. Dalakas
  • J. Peripher. Nerv. Syst. 16,
  • 2011

a report of 13 cases and review of the literature

Benedetti, L. et al. Rituximab in patients with chronic inflamma polyradiculoneuropathy
  • J. Neurol. Neurosurg. Psychiatry 82, 306–308
  • 2011